Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis.
Rituximab therapy for juvenile-onset systemic lupus erythematosus.
Pediatr. Nephrol., Mar;23(3):413-9 (2008)
Obesity and preterm birth: additive risks in the progression of kidney disease in children.
Pediatr. Nephrol., Jul;24(7):1363-70 (2009)
Vitamin D insufficiency and deficiency in children with early chronic kidney disease.
J. Pediatr., Jun;154(6):906-11.e1 (2009)
A renal protocol for all ages and all indications: mercapto-acetyl-triglycine (MAG3) with simultaneous injection of furosemide (MAG3-F0): a 17-year experience.
Semin Nucl Med., May;39(3):156-73 (2009)
Two decades of pediatric kidney transplantation in a multi-ethnic cohort.
Pediatr Transplant., Aug;14(5):667-74 (2010)
Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation.
Pediatr Transplant., Feb;15(1):37-46 (2011)
Long-term risk of chronic kidney disease in unilateral multicystic dysplastic kidney.
Pediatr. Nephrol., Apr;26(4):597-603 (2011)
Three decades of progress in treating childhood-onset lupus nephritis.
Clin J Am Soc Nephrol., Sep;6(9):2192-9 (2011)
A child with BK virus infection: Inadequacy of current therapeutic strategies.
Pediatr Transplant., Nov (2011)
Twenty-five years of infant dialysis: a single center experience.
J. Pediatr., Jul;155(1):111-7 (2009)